For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
How to plan for unanticipated interactions during surgical energy device development that limit performance and frustrate ...
“Trans auricular vagus nerve stimulation (taVNS) is one of the less invasive approaches to modulate brain function in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results